Dr. Owonikoko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S. Greene Street N9E22
Baltimore, MD 21201Phone+1 410-328-5506- Is this information wrong?
Summary
- Taofeek K. Owonikoko, MD, PhD, is the Executive Director of the University of Maryland’s NCI-designated Marlene and Stewart Greenebaum Comprehensive Cancer Center. He is also the Senior Associate Dean of Cancer Programs at the University of Maryland’s School of Medicine and is the Associate Vice President of Cancer Programs at the University of Maryland, Baltimore.
He is a translational Physician-Scientist, board-certified in Medical Oncology, Hematology, and Internal Medicine with a clinical focus on treating patients with lung cancer. His research interests span the spectrum of preclinical experimental therapeutics, biomarker discovery, and translation of promising laboratory findings into clinical trials. Furthermore, he serves as an elected Board Member and Treasurer-Elect of the American Society of Clinical Oncology (ASCO). He is additionally an Editorial Board Member for several highly regarded academic journals including Cancer, Frontiers in Oncology, Journal of Thoracic Disease, and Translational Lung Cancer Research. Dr. Owonikoko is a member of the American College of Physicians, American Society for Hematology, the Society for Immunotherapy of Cancer, and the International Association for the Study of Lung Cancer, just to name a few. Lastly, he has been an NIH Study Section Member for the past eleven years.
Dr. Owonikoko has authored/co-authored over 250+ peer-reviewed original manuscripts in leading journals including the New England Journal of Medicine, Lancet, Cell, Science, Nature, JCO, Lancet Oncology, Cancer Discovery, and Cancer Cell. His work has been broadly cited with more than 49,000 citations and an h-index of 86. He has received peer-reviewed extramural grant funding in support of his research from the US National Institutes of Health, Department of Defense, private foundations, and pharmaceutical partners.
Clinical Expertise
- General medical oncology, Endocrine oncology, Head and neck oncology, Thoracic oncology, Lung cancer
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2005 - 2008
- Graduate HospitalResidency, Internal Medicine, 2002 - 2005
- Obafemi Awolowo University College of Health SciencesClass of 1991
Certifications & Licensure
- MD State Medical License 2023 - 2025
- PA State Medical License 2002 - 2024
- GA State Medical License 2008 - 2022
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Dr. Larry E. Davis Excellence in the Academy – Leadership Award University of Pittsburgh Office of the Provost, 2023
- Bruell Memorial Lung Cancer Lecture The Cleveland Clinic Cancer Center, 2022
- Michaele C. Christian Oncology Development Award and Lectureship National Cancer Institute (NCI) Cancer Treatment Evaluation Program (CTEP), 2020
- Join now to see all
Clinical Trials
- A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
- Study of Everolimus (RAD001) in Combination With Lenalidomide Start of enrollment: 2010 Sep 09
- Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- SCLC Classification by Platinum Sensitivity in the Era of Immunotherapy: Mere Relic or a Valuable Treasure to Keep?Owonikoko, T.> ;Journal of Thoracic Oncology. 2024 Feb 1
- Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.Choe, J., Babajanyan, S., Gianoukakis, A., Bowles, D., Owonikoko, T., Worden, F., Wirth, L., Brose, M.> ;European Thyroid Journal. 2024 Feb 1
- Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera, Mehmet A Bilen, Taofeek K Owonikoko, Jonathan L Kaufman, Ajay K Nooka, Colleen M Lewis, Elise Hitron, Hannah ...> ;The Oncologist. 2023 Dec 11
- Join now to see all
Journal Articles
- Efficacy of Selpercatinib in RET-Altered Thyroid CancersLori J Wirth, Jochen Lorch, Francis Worden, Marcia Brose, Taofeek K Owonikoko, Mark E Burkard, Todd M Bauer, Viola W Zhu, Nehal Lakhani, Victor Moreno, Manisha H Shah, New England Journal of Medicine
- Concurrent Chemoradiotherapy with Weekly Versus Triweekly Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Comparative AnalysisRathi Pillai, Fadlo R Khuri, Nabil F Saba, Conor Steuer, Suchita Pakkala, Kristin Higgins, Jonathan J Beitler, Suresh S Ramalingam, Brandon Twardy, Kelly Schrapp, Taof..., Head & Neck
- Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with RadiotherapyGabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer
- Join now to see all
Authored Content
- Efficacy of Selpercatinib in RET-Altered Thyroid CancersAugust 2020
- Efficacy of Selpercatinib in RET-Altered Thyroid CancersAugust 2020
- Efficacy of Selpercatinib in RET-Altered Thyroid CancersAugust 2020
Press Mentions
- Internationally-Recognized Thoracic Oncologist Dr. Taofeek K. Owonikoko Named Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterOctober 12th, 2023
- University of Maryland Greenebaum Comprehensive Cancer Center and AstraZeneca Partner to Enhance Community Based Lung Cancer Screening and Detection for Marylanders at High RiskApril 25th, 2024
Professional Memberships
- Member
- Member
- Member
- Member
- International Association for the Study of Lung Cancer (IASLC)Member
- Georgian Society of Clinical Oncology (GASCO)Member
- Georgia Center for Oncology Research and Education (GA – CORE)Member
- American Society for Cancer Research (AACR)Member
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Hospital Affiliations
- University of Maryland Medical CenterBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: